Jeffrey S. Glenn

Insider Reports History

Entity
Individual
Location
350 Cambridge Avenue, Suite 350, Palo Alto, CA
Signature
/s/ Jeffrey S. Glenn
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey S. Glenn:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Eiger BioPharmaceuticals, Inc. Director Stock Option (Right to Buy) 28K Mar 1, 2023 Direct

Insider Reports Filed by Jeffrey S. Glenn

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EIGR Eiger BioPharmaceuticals, Inc. Mar 1, 2023 1 $0 4 Mar 3, 2023 Director
EIGR Eiger BioPharmaceuticals, Inc. Dec 22, 2022 1 $128K 4 Dec 27, 2022 Director
EIGR Eiger BioPharmaceuticals, Inc. Mar 11, 2022 2 $0 4 Mar 11, 2022 Director